2023. In silico studies of quinazolinone analogues to distinguish their hypothetical binding mode using the X-ray crystal structure human carbon anhydrase II (HCAII) enzyme complex with sugar sulfamate for anticonvulsant activity. International Journal of Pharmaceutical Sciences and Drug Research. 15, 5 (Sep. 2023), 675–679. DOI:https://doi.org/10.25004/IJPSDR.2023.150516.